Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Suicide attempt history, childhood trauma, and functional brain network alterations in major depressive disorder: a resting-state functional connectivity-based multivariate pattern analysis
    Published on 2026-01-08
    8 months ago
  • Inactivation of NMDAR and CaMKII signaling within the prelimbic cortex blocks incubated cocaine- and sucrose-craving
    Published on 2026-01-07
    8 months ago
  • Differential neural responses to rhythmic and patterned TMS protocols: Insights from EEG spectral analysis
    Published on 2026-01-06
    8 months ago
  • The positive allosteric modulator GNE-9278 increases gating, conductance, and Ca2+ permeability for GluN2D-containing NMDA receptors
    Published on 2026-01-06
    8 months ago
  • Karl Rickels, MD (1924–2025)
    Published on 2026-01-06
    8 months ago
  • Imaging brain energetics to advance metabolic psychiatry
    Published on 2025-12-26
    9 months ago
  • Identification of a stress-sensitive endogenous opioid-containing neuronal population in the paranigral ventral tegmental area
    Published on 2025-12-19
    9 months ago
« Previous 1 … 35 36 37 38 39 … 143 Next »
Journal of Psychopharmacology
  • Pictorial representation of illness and self measure (PRISM): A putative transdiagnostic tool for evaluating therapeutic effects of psychedelic treatments
    Published on 2025-05-05
    1 year ago
  • Oral esketamine for patients with severe treatment-resistant depression: Effectiveness, safety, and tolerability of a six-week open-label treatment program
    Published on 2025-04-26
    1 year ago
  • Therapeutic effects of resveratrol on memory deficits in offspring of sleep-deprived rats: Involvement of hippocampal BDNF-TrkB pathways
    Published on 2025-04-24
    1 year ago
  • Peri-traumatic consumption of classic psychedelics is associated with lower anxiety and post-traumatic responses 3 weeks after exposure
    Published on 2025-04-21
    1 year ago
  • Daily supplementation with lemon verbena extract decreases subjective energy and parental reports of hyperactivity in children displaying sub-clinical attention deficit hyperactivity disorder-type behaviours: A randomised controlled trial
    Published on 2025-04-19
    1 year ago
  • Pharmacokinetics and pharmacodynamics of sublingual microdosed lysergic acid diethylamide in healthy adult volunteers
    Published on 2025-04-19
    1 year ago
  • Psilocybin and ketamine affect novel neuropeptides gene expression in the rat hypothalamus
    Published on 2025-04-17
    1 year ago
« Previous 1 … 35 36 37 38 39 … 154 Next »
European Neuropsychopharmacology
  • Genomic evidence of GLP-1 receptor as target for the treatment of substance use disorders
    Published on 2024-12-23
    2 years ago
  • Opportunities to advance microRNA research in psychiatry
    Published on 2024-12-23
    2 years ago
  • Respiratory health in serious mental illness
    Published on 2024-12-23
    2 years ago
  • Contrasting genetic burden for bipolar disorder: Early onset versus late onset in an older adult bipolar disorder sample
    Published on 2024-12-22
    2 years ago
  • Predicting the past: The risks and rewards of post-hoc findings
    Published on 2024-12-22
    2 years ago
  • Retinal structure and its relationship with premorbid, clinical, and cognitive variables in young Spanish patients with early course schizophrenia spectrum disorders
    Published on 2024-12-22
    2 years ago
  • Redefining schizophrenia treatment with muscarinic modulation—A perspective
    Published on 2024-12-06
    2 years ago
« Previous 1 … 35 36 37 38 39 … 170 Next »

   Pharma Pub